Industry
Biotechnology and Pharmaceuticals In the complex word of investments, JR Capital experts provide the investment community with a unique partnership to identify and qualify bio-pharmaceutical investment opportunities. Our strength is in the analysis of cross border scientific, regulatory, intellectual property and other related components of investment target.
Our business strategy is designed for maximizing clinical and commercial potential of our product portfolio with our global platform. Through our approach, we have created a pipeline of marketed products and development-stage assets that we believe will provide us and our partners with diversified long-term revenue stream.
Medical Devices For the past ten years, JR Capital has been an innovative player to help funding entrepreneurs to grow their business in medical devices business. We are actively in the segments of IVD, hemodialysis center, neurosurgery supplies, orthopedic implant and ophthalmic supplies.
Health Care Services JR Capital is one of the industry leaders in private hospitals in China. JR Capital has invested into and helped to build a number of specialist chain hospitals in the field of ophthalmology, orthopaedic and rehabilitation. As an investment banking firm, JR Capital has advised more than 10 hospitals to become public listed entities.
Biotechnology and Pharmaceuticals In the complex word of investments, JR Capital experts provide the investment community with a unique partnership to identify and qualify bio-pharmaceutical investment opportunities. Our strength is in the analysis of cross border scientific, regulatory, intellectual property and other related components of investment target.
Our business strategy is designed for maximizing clinical and commercial potential of our product portfolio with our global platform. Through our approach, we have created a pipeline of marketed products and development-stage assets that we believe will provide us and our partners with diversified long-term revenue stream.
Medical Devices For the past ten years, JR Capital has been an innovative player to help funding entrepreneurs to grow their business in medical devices business. We are actively in the segments of IVD, hemodialysis center, neurosurgery supplies, orthopedic implant and ophthalmic supplies.
Health Care Services JR Capital is one of the industry leaders in private hospitals in China. JR Capital has invested into and helped to build a number of specialist chain hospitals in the field of ophthalmology, orthopaedic and rehabilitation. As an investment banking firm, JR Capital has advised more than 10 hospitals to become public listed entities.
Biotechnology
The Biotech Licensing Business Experiences Rapid Growth
China's biotechnology industry has grown tremendously after ten years of development. It is entering a turning point of great opportunities for rapid development. A large number of innovations are driving the boom of the biotechnology industry, and there will soon no longer be a shortage of effective, modern medicines. The Chinese government is implementing a series of comprehensive science and technology plans to vigorously support innovative biotechnology companies and cultivate biomedicine as a new economic growth point.
READ MORE
Newsroom
EXPLORE MORE
Rare genetic variants confer largest increase in type 2 diabetes risk seen to date
July 7 , 2021
Scientists at the University of Cambridge have identified rare genetic variants—carried by one in 3,000 people—that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect.
READ MORE
Researchers discover way to improve immune response July 6 , 2021 Melbourne researchers have identified a way to improve the immune response in the face of severe viral infections.READ MORE
Structures discovered in brain cancer patients can help fight tumors July 5 , 2021 Researchers at Uppsala University have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour. They also found that immunotherapy enhanced the formation of these structures in a mouse model. This discovery suggests new opportunities to regulate the anti-tumour response of the immune system.READ MORE